NCT00015899View on ClinicalTrials.gov

SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

September 30, 2005

Study Completion Date

March 31, 2007

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

lonafarnib

Trial Locations (9)

15213

Children's Hospital of Pittsburgh, Pittsburgh

27710

Duke Comprehensive Cancer Center, Durham

98105

Children's Hospital and Regional Medical Center - Seattle, Seattle

94143-0372

UCSF Comprehensive Cancer Center, San Francisco

20010-2970

Children's National Medical Center, Washington D.C.

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

19104-4318

Children's Hospital of Philadelphia, Philadelphia

38105-2794

St. Jude Children's Research Hospital, Memphis

77030-2399

Texas Children's Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Pediatric Brain Tumor Consortium

NETWORK

NCT00015899 - SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors | Biotech Hunter | Biotech Hunter